Otsuka America Pharmaceutical - North American BreathTek Business $XXM Meridian 3 Compare Otsuka America Pharmaceutical to Competitors Angelini Pharma Angelini Pharma is a pharmaceutical company with a focus on
Otsuka America Pharmaceutical operates within the healthcare sector, focusing on the development and commercialization of pharmaceutical products. Use the CB Insights Platform to explore Otsuka America Pharmaceutical's full profile.
Courtesy of Otsuka America Pharmaceutical Inc. Company InformationBest Workplaces In New YorkBest Workplaces In Biopharma Updated:9/12/24 Country:U.S. Headquarters:Princeton, N.J. Industry:Biotechnology & Pharmaceuticals CEO: Website:https://www.otsuka-us.com/ ...
基本信息 企业注册号 0934701 企业名称 OTSUKA AMERICA PHARMACEUTICAL,INC. 企业状态 ACTIVE 成立日期 2008-04-09 企业类型 Stock 注册地 CONNECTICUT(康涅狄格州) 管辖区域 DELAWARE 代理人/机构名称 C T CORPORATION SYSTEM 代理人/机构地址 67 BURNSIDE AVE, EAST HARTFORD, CT, 06108-3408, United States ...
2025-01-31 04:42 amSUN PHARMACEUTICAL INDUSTRIES LTD.: Q3 2025 Earnings Release Quarterly revenue - Rate of surprise Net sales - Rate of surprise Annual profits - Rate of surprise IndicesEuropeAmericaAsia S&P 500 6,068 +0.03% DOW JONES ...
The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, ...
TOKYO--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. is pleased to announce an agreement with Avanir Pharmaceuticals, Inc. (“Avanir”) in which Otsuka America, Inc., a US subsidiary, acquires Avanir for USD 3.5 billion in an all-cash tender offer. The contract was signed on December ...
Fidelity Advisor Global Commodity Stock Fund - Class M 0.00% SACEX $0.00 Spirit of America Energy Fund Class C 0.00% PRRMF $0.00 Premium Income Corporation 0.00% FGFPP $0.00 Fundamental Global Inc. 8.00% CUM PRE STK SERIES A 0.00%
The dosage of these pharmaceutical preparations of the invention may be selected appropriately depending on the method of administration, the patient's age, sex and other factors, severity of the disease and other factors. Generally, however, the daily dose of the active ingredient compound is pref...